Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Nevamast crema
- Development stage
- Unknown
- Lead developer
- Epitech
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
NEVAMAST® CREMA is a topical medical device developed by Epitech Group SpA for the symptomatic treatment of swelling, fatigue, and pain in the lower limbs associated with chronic venous insufficiency (CVI), microcirculatory disorders, and podological conditions. It utilizes the ALIAmide (Autacoid Local Injury Antagonism) mechanism, which involves the modulation of mast cells and other non-neuronal immune cells to control neuroinflammation and tissue reactivity. The product is classified as a Class C Medical Device in Italy and is part of a broader product family that includes oral and gel formulations. The cream is intended for twice-daily topical application to the affected areas of the foot, ankle, and leg.
- Brand names
- Nevamast cremaNevamast
- Other names
- NEVAMAST® CREMA
Beyond the preview
Go deeper on Nevamast crema.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nevamast crema.